MANKIND Quarterly Results, Profit & Loss, Balance Sheet (MANKIND)

MANKIND quarterly results and annual financials: sales, operating profit, OPM, net profit, EPS, balance sheet, cash flow and ratios like ROCE, with YoY and QoQ growth.

  • MANKIND Financials
  • MANKIND Shareholding Pattern
  • MANKIND Earnings Documents
  • MANKIND Announcements
  • MANKIND Corporate Actions
  • MANKIND Bulk, Block & Insider Deals
  • MANKIND Delivery Data
  • MANKIND Earnings Concalls
  • Market Timeline
  • Concall Monitor
  • Company Research
  • Earnings Monitor
  • Upcoming Results
  • Sector Monitor
  • Sector Performance
  • Bulk & Block Deals
  • Delivery Data
  • FII & DII Activity
  • Market Indices
  • Plans & Pricing

Mankind Pharma Ltd (MANKIND) Financials - Quarterly Results, Profit & Loss, Balance Sheet, Cash Flow

Mankind Pharma Ltd reported sales of ₹4,338 Cr, operating profit of ₹1,171 Cr (OPM 27%) and net profit of ₹716 Cr for the quarter ended Sep 2026. Figures in ₹ crore, consolidated where available.

MANKIND quarterly results (₹ Cr)
MetricDec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Sales3,1993,0793,5703,6973,5673,4434,0314,338
Expenses2,3832,3962,7242,7762,6482,5132,9743,167
Operating Profit8166838479219199301,0561,171
OPM26%22%24%25%26%27%26%27%
Other Income872498394-31944999
Interest221191171170157142110105
Depreciation187231219222223223226236
Profit before tax495511540624509659769929
Tax22%17%18%17%19%15%25%23%
Net Profit385425445520414559574716
EPS in Rs9.2210.210.6212.399.913.4313.7517.23
MANKIND profit & loss, annual (₹ Cr)
MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales7,7828,74910,26012,20714,27815,379
Expenses5,7916,8487,7439,18210,65311,302
Operating Profit1,9911,9022,5173,0263,6254,077
OPM26%22%25%25%25%27%
Other Income210141295548238211
Interest604634432644514
Depreciation167326378621886907
Profit before tax1,9751,6712,3992,5212,3332,867
Tax26%22%19%20%17%-
Net Profit1,4531,3101,9422,0111,9382,264
EPS in Rs35.783247.7548.2646.3454.31
Dividend Payout0%0%0%0%2%-
MANKIND balance sheet (₹ Cr)
MetricMar 2024Mar 2025Sep 2025Mar 2026Sep 2026
Equity Capital4041414141
Reserves9,32314,29115,24516,25917,541
Borrowings2078,5118,3696,3125,422
Other Liabilities2,3134,8085,1595,1435,950
Total Liabilities11,88327,65228,81327,75528,954
Fixed Assets4,54519,00519,26318,62018,854
CWIP2828263941,128752
Investments2,5682,0422,9471,9851,909
Other Assets4,4885,7806,2096,0227,439
Total Assets11,88327,65228,81327,75528,954
MANKIND cash flows (₹ Cr)
MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity9201,8132,1522,4133,121
Cash from Investing Activity-1,369-1,052-2,081-12,624-181
Cash from Financing Activity605-740510,233-2,953
Net Cash Flow156227722-12
Free Cash Flow-1,4239871,7711,8952,387
CFO/OP71%112%103%98%102%
CFO/EBITDAShare of operating profit converting into cash: CFO (before tax) / Operating Profit7111210398102
MANKIND ratios
MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days1824304644
Inventory Days265188180219193
Days Payable16212690119121
Cash Conversion Cycle12186120146117
Working Capital Days243953-28-40
ROCE32%22%26%17%14%
  • MANKIND Shareholding Pattern
  • MANKIND Earnings Concalls
  • MANKIND Growth Catalysts
  • MANKIND Corporate Actions
  • MANKIND Announcements
  • MANKIND Results & Documents
  • MANKIND Bulk & Block Deals
  • MANKIND Delivery Data